Statistical Interpretation of CA125 and Bcl-2 in Serum of Patients With Late Stage Ovarian Cancer


Camlica H., Duranyildiz D., Tas F., Yasasever V.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.31, no.6, pp.585-588, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 6
  • Publication Date: 2008
  • Doi Number: 10.1097/coc.0b013e318174dbd2
  • Journal Name: AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.585-588
  • Keywords: statistical approach, tumor marker, CA125-Bcl-2 combination, ovarian cancer, PROGNOSTIC-SIGNIFICANCE, P53, CARCINOMA, APOPTOSIS, MARKERS, PREDICTION, REGULATORS, EXPRESSION, PROTEINS, TUMORS
  • Istanbul University Affiliated: Yes

Abstract

Objectives: The present study was conducted to investigate the sensitivity, specificity, predictive values and accuracy of serum CA 125 and Bcl-2 levels and their combination in advanced epithelial ovarian cancer patients.